Cancer

Showing 26 - 50 of 3,028

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Cancer, Heart Failure, Arrhythmia Trial in Harbin (Control group:DH001 , Trial group: DH001 low-dose group, Trial group: DH001

Recruiting
  • Cancer
  • +4 more
  • Control group:DH001 placebo
  • +2 more
  • Harbin, Heilongjiang, China
    Harbin Institute of Hematology and Cancer
Oct 20, 2023

Genetic Disease, Cancer, Cardiovascular Diseases Trial in Philadelphia (private web-portal eHealth disclosure of genetic

Enrolling by invitation
  • Genetic Disease
  • +2 more
  • private web-portal eHealth disclosure of genetic results
  • eHealth education intervention (web or chatbot)
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Oct 18, 2023

Cancer, Immune-related Adverse Event Trial in Durham (Medical chart review)

Enrolling by invitation
  • Cancer
  • Immune-related Adverse Event
  • Medical chart review
  • Durham, North Carolina
    Duke University Medical Center
Oct 20, 2023

INvestigating DIGital Outcomes in the Community

Not yet recruiting
  • Cancer
    • London, United Kingdom
      Imperial College Healthcare NHS Trust
    Oct 17, 2023

    Cancer, Tumor, Solid, Malignant Tumor Trial (OR502, Cemiplimab)

    Not yet recruiting
    • Cancer
    • +6 more
    • (no location specified)
    Oct 16, 2023

    Cancer, Psychosocial Problem, Gastrointestinal Dysfunction Trial (Multistrain Probiotic, Placebo)

    Not yet recruiting
    • Cancer
    • +2 more
    • Multistrain Probiotic
    • Placebo
    • (no location specified)
    Oct 12, 2023

    Cancer, Telemonitoring, Telemedicine Trial in Santiago (Contigo Application)

    Not yet recruiting
    • Cancer
    • +4 more
    • Contigo Application
    • Santiago, Chile
      UC Christus Cancer Centre
    Oct 10, 2023

    Public Survey on Breath Testing for Health and Disease

    Recruiting
    • Cancer
    • +5 more
    • Survey
    • London, United Kingdom
      Imperial College London
    Oct 16, 2023

    Cancer Trial in Pittsburgh (Dose esclated resistance training)

    Recruiting
    • Cancer
    • Dose esclated resistance training
    • Pittsburgh, Pennsylvania
      AHN CI Exercise Oncology and Resiliency Center
    Oct 9, 2023

    The Living With a Long-Term Condition Study

    Recruiting
    • Asthma
    • +44 more
    • Living with LTC Questionnaire
    • London, United Kingdom
      King's College London
    Oct 10, 2023

    Cancer, Chemotherapeutic Agent Toxicity Trial in Santiago (Contigo Application)

    Not yet recruiting
    • Cancer
    • Chemotherapeutic Agent Toxicity
    • Contigo Application
    • Santiago, Chile
      Complejo Asistencial Dr. Sotero del Río
    Oct 10, 2023

    Cancer Trial (P-OMICs-flow services)

    Not yet recruiting
    • Cancer
    • P-OMICs-flow services
    • (no location specified)
    Oct 4, 2023

    Caring for Sexual Health and Wellbeing of Cancer Survivors and

    Completed
    • Cancer
    • No intervention
    • Bournemouth, Dorset, United Kingdom
      Bournemouth University
    Oct 6, 2023

    Cancer, Solid Tumor, Thromboembolism Trial in Tripoli (Palbociclib, Rivaroxaban, SNP)

    Recruiting
    • Cancer
    • +12 more
    • Tripoli, North Lebanon, Lebanon
    • +1 more
    Oct 5, 2023

    Cancer Trial in London (Exercise to a Heart Rate (HR) Zone)

    Recruiting
    • Cancer
    • Exercise to a Heart Rate (HR) Zone
    • London, United Kingdom
    • +1 more
    Oct 2, 2023

    Cancer, Peritoneal Carcinomatosis Trial in Brussels (FAPI PET/CT)

    Recruiting
    • Cancer
    • Peritoneal Carcinomatosis
    • FAPI PET/CT
    • Brussels, Belgium
      Institut Jules Bordet
    Sep 25, 2023

    Cancer, Metastatic Castration-resistant Prostate Cancer, mCRPC Trial (INKmune)

    Not yet recruiting
    • Cancer
    • +2 more
    • INKmune
    • (no location specified)
    Sep 27, 2023

    Cancer Trial in Shenyang (Nutritional therapy)

    Recruiting
    • Cancer
    • Nutritional therapy
    • Shenyang, Liaoning, China
      The First Affiliated Hospital of China Medical University
    Sep 22, 2023

    Solid Tumor, Adult, Colorectal Cancer, NSCLC Trial in United States (A2B694, xT CDx with HLA-LOH Assay)

    Not yet recruiting
    • Solid Tumor, Adult
    • +19 more
    • A2B694
    • xT CDx with HLA-LOH Assay
    • Duarte, California
    • +9 more
    Sep 22, 2023

    Cancer, Chronic Heart Failure, COPD Trial in Münster (Telemedicine)

    Completed
    • Cancer
    • +3 more
    • Telemedicine
    • Münster, Germany
      University Hospital Muenster
    Sep 21, 2023

    Malnutrition, Cancer, IBD Trial in Spain (Fortimel)

    Recruiting
    • Malnutrition
    • +4 more
    • Fortimel
    • Bilbao, Spain
    • +5 more
    Sep 20, 2023

    Outcome Evaluation After Fertility Preservation

    Recruiting
    • Cancer
    • Fertility Issues
    • This is an observational cohort study
    • Hong Kong, Hong Kong
      Prince of Wales Hospital
    Sep 21, 2023

    The Gut Microbiome and Immunotherapy Response in Solid Cancers

    Recruiting
    • Cancer
      • Galveston, Texas
        University of Texas Medical Branch
      Sep 15, 2023

      Cancer Trial in Tampa (Pickleball)

      Recruiting
      • Cancer
      • Pickleball
      • Tampa, Florida
        Moffitt Cancer Center
      Sep 15, 2023

      HLA-DR in Cell Cultures Isolated From Primary Squamous Cell

      Active, not recruiting
      • Squamous Cell Carcinoma of the Head and Neck
      • Cancer
      • cell culture
      • Roma, Lazio, Italy
        Fondazione Policlinico Universitario Gemelli, Irccs
      Sep 11, 2023